+1 (704) 266-3234
+1 (704) 266-3234You are here :
Published on: Nov 2022 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 113
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Prostate Cancer Molecular Diagnostics companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Prostate Cancer Molecular Diagnostics market. Further, it explains the major drivers and regional dynamics of the global Prostate Cancer Molecular Diagnostics market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Qiagen
Foundationmedicine
Genetech
Gpmedical
Premed
Berryoncology
Gene+
Annoroad
Topgen
Geneis
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Prostate Cancer Molecular Diagnostics Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip
Prostate Cancer Molecular Diagnostics Segment by Application
Clinical Diagnosis
Drug Screening
Research
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Prostate Cancer Molecular Diagnostics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Prostate Cancer Molecular Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Prostate Cancer Molecular Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Prostate Cancer Molecular Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Prostate Cancer Molecular Diagnostics revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Prostate Cancer Molecular Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Prostate Cancer Molecular Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Qiagen, Foundationmedicine, Genetech, Gpmedical, Premed, Berryoncology, Gene+, Annoroad and Topgen, etc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Prostate Cancer Molecular Diagnostics Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Prostate Cancer Molecular Diagnostics Market Size (2017-2028)
2.2 Prostate Cancer Molecular Diagnostics Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Prostate Cancer Molecular Diagnostics Market Size by Region (2017-2022)
2.4 Global Prostate Cancer Molecular Diagnostics Market Size Forecast by Region (2023-2028)
2.5 Global Top Prostate Cancer Molecular Diagnostics Countries Ranking by Market Size
3 Prostate Cancer Molecular Diagnostics Competitive by Company
3.1 Global Prostate Cancer Molecular Diagnostics Revenue by Players
3.1.1 Global Prostate Cancer Molecular Diagnostics Revenue by Players (2017-2022)
3.1.2 Global Prostate Cancer Molecular Diagnostics Market Share by Players (2017-2022)
3.2 Global Prostate Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Prostate Cancer Molecular Diagnostics Revenue
3.4 Global Prostate Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Prostate Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Molecular Diagnostics Revenue in 2021
3.5 Global Prostate Cancer Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Prostate Cancer Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Prostate Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Prostate Cancer Molecular Diagnostics Historic Revenue by Type (2017-2022)
4.2 Global Prostate Cancer Molecular Diagnostics Forecasted Revenue by Type (2023-2028)
5 Global Prostate Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Prostate Cancer Molecular Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Prostate Cancer Molecular Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Prostate Cancer Molecular Diagnostics Revenue by Company (2020-2022)
6.2 North America Prostate Cancer Molecular Diagnostics Revenue by Type (2017-2028)
6.3 North America Prostate Cancer Molecular Diagnostics Revenue by Application (2017-2028)
6.4 North America Prostate Cancer Molecular Diagnostics Revenue by Country (2017-2028)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Prostate Cancer Molecular Diagnostics Revenue by Company (2020-2022)
7.2 Europe Prostate Cancer Molecular Diagnostics Revenue by Type (2017-2028)
7.3 Europe Prostate Cancer Molecular Diagnostics Revenue by Application (2017-2028)
7.4 Europe Prostate Cancer Molecular Diagnostics Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Prostate Cancer Molecular Diagnostics Revenue by Company (2020-2022)
8.2 Asia Pacific Prostate Cancer Molecular Diagnostics Revenue by Type (2017-2028)
8.3 Asia Pacific Prostate Cancer Molecular Diagnostics Revenue by Application (2017-2028)
8.4 Asia Pacific Prostate Cancer Molecular Diagnostics Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Prostate Cancer Molecular Diagnostics Revenue by Company (2020-2022)
9.2 Latin America Prostate Cancer Molecular Diagnostics Revenue by Type (2017-2028)
9.3 Latin America Prostate Cancer Molecular Diagnostics Revenue by Application (2017-2028)
9.4 Latin America Prostate Cancer Molecular Diagnostics Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Prostate Cancer Molecular Diagnostics Revenue by Company (2020-2022)
10.2 Middle East and Africa Prostate Cancer Molecular Diagnostics Revenue by Type (2017-2028)
10.3 Middle East and Africa Prostate Cancer Molecular Diagnostics Revenue by Application (2017-2028)
10.4 Middle East and Africa Prostate Cancer Molecular Diagnostics Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Qiagen
11.1.1 Qiagen Company Details
11.1.2 Qiagen Business Overview
11.1.3 Qiagen Prostate Cancer Molecular Diagnostics Products and Services
11.1.4 Qiagen Prostate Cancer Molecular Diagnostics Revenue in Prostate Cancer Molecular Diagnostics Business (2017-2022)
11.1.5 Qiagen Prostate Cancer Molecular Diagnostics SWOT Analysis
11.1.6 Qiagen Recent Developments
11.2 Foundationmedicine
11.2.1 Foundationmedicine Company Details
11.2.2 Foundationmedicine Business Overview
11.2.3 Foundationmedicine Prostate Cancer Molecular Diagnostics Products and Services
11.2.4 Foundationmedicine Prostate Cancer Molecular Diagnostics Revenue in Prostate Cancer Molecular Diagnostics Business (2017-2022)
11.2.5 Foundationmedicine Prostate Cancer Molecular Diagnostics SWOT Analysis
11.2.6 Foundationmedicine Recent Developments
11.3 Genetech
11.3.1 Genetech Company Details
11.3.2 Genetech Business Overview
11.3.3 Genetech Prostate Cancer Molecular Diagnostics Products and Services
11.3.4 Genetech Prostate Cancer Molecular Diagnostics Revenue in Prostate Cancer Molecular Diagnostics Business (2017-2022)
11.3.5 Genetech Prostate Cancer Molecular Diagnostics SWOT Analysis
11.3.6 Genetech Recent Developments
11.4 Gpmedical
11.4.1 Gpmedical Company Details
11.4.2 Gpmedical Business Overview
11.4.3 Gpmedical Prostate Cancer Molecular Diagnostics Products and Services
11.4.4 Gpmedical Prostate Cancer Molecular Diagnostics Revenue in Prostate Cancer Molecular Diagnostics Business (2017-2022)
11.4.5 Gpmedical Prostate Cancer Molecular Diagnostics SWOT Analysis
11.4.6 Gpmedical Recent Developments
11.5 Premed
11.5.1 Premed Company Details
11.5.2 Premed Business Overview
11.5.3 Premed Prostate Cancer Molecular Diagnostics Products and Services
11.5.4 Premed Prostate Cancer Molecular Diagnostics Revenue in Prostate Cancer Molecular Diagnostics Business (2017-2022)
11.5.5 Premed Prostate Cancer Molecular Diagnostics SWOT Analysis
11.5.6 Premed Recent Developments
11.6 Berryoncology
11.6.1 Berryoncology Company Details
11.6.2 Berryoncology Business Overview
11.6.3 Berryoncology Prostate Cancer Molecular Diagnostics Products and Services
11.6.4 Berryoncology Prostate Cancer Molecular Diagnostics Revenue in Prostate Cancer Molecular Diagnostics Business (2017-2022)
11.6.5 Berryoncology Prostate Cancer Molecular Diagnostics SWOT Analysis
11.6.6 Berryoncology Recent Developments
11.7 Gene+
11.7.1 Gene+ Company Details
11.7.2 Gene+ Business Overview
11.7.3 Gene+ Prostate Cancer Molecular Diagnostics Products and Services
11.7.4 Gene+ Prostate Cancer Molecular Diagnostics Revenue in Prostate Cancer Molecular Diagnostics Business (2017-2022)
11.7.5 Gene+ Prostate Cancer Molecular Diagnostics SWOT Analysis
11.7.6 Gene+ Recent Developments
11.8 Annoroad
11.8.1 Annoroad Company Details
11.8.2 Annoroad Business Overview
11.8.3 Annoroad Prostate Cancer Molecular Diagnostics Products and Services
11.8.4 Annoroad Prostate Cancer Molecular Diagnostics Revenue in Prostate Cancer Molecular Diagnostics Business (2017-2022)
11.8.5 Annoroad Prostate Cancer Molecular Diagnostics SWOT Analysis
11.8.6 Annoroad Recent Developments
11.9 Topgen
11.9.1 Topgen Company Details
11.9.2 Topgen Business Overview
11.9.3 Topgen Prostate Cancer Molecular Diagnostics Products and Services
11.9.4 Topgen Prostate Cancer Molecular Diagnostics Revenue in Prostate Cancer Molecular Diagnostics Business (2017-2022)
11.9.5 Topgen Prostate Cancer Molecular Diagnostics SWOT Analysis
11.9.6 Topgen Recent Developments
11.10 Geneis
11.10.1 Geneis Company Details
11.10.2 Geneis Business Overview
11.10.3 Geneis Prostate Cancer Molecular Diagnostics Products and Services
11.10.4 Geneis Prostate Cancer Molecular Diagnostics Revenue in Prostate Cancer Molecular Diagnostics Business (2017-2022)
11.10.5 Geneis Prostate Cancer Molecular Diagnostics SWOT Analysis
11.10.6 Geneis Recent Developments
12 Prostate Cancer Molecular Diagnostics Market Dynamics
12.1 Prostate Cancer Molecular Diagnostics Market Trends
12.2 Prostate Cancer Molecular Diagnostics Market Drivers
12.3 Prostate Cancer Molecular Diagnostics Market Challenges
12.4 Prostate Cancer Molecular Diagnostics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Prostate Cancer Molecular Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Prostate Cancer Molecular Diagnostics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Prostate Cancer Molecular Diagnostics Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Region (2017-2022)
Table 10. Global Prostate Cancer Molecular Diagnostics Revenue by Players (2017-2022) & (US$ Million)
Table 11. Global Prostate Cancer Molecular Diagnostics Market Share by Players (2017-2022)
Table 12. Global Top Prostate Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Molecular Diagnostics as of 2021)
Table 13. Ranking of Global Top Prostate Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2021
Table 14. Global 5 Largest Players Market Share by Prostate Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2017-2022)
Table 15. Key Players Headquarters and Area Served
Table 16. Key Players Prostate Cancer Molecular Diagnostics Product Solution and Service
Table 17. Date of Key Manufacturers Enter into Prostate Cancer Molecular Diagnostics Market
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global Prostate Cancer Molecular Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 20. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Type (2017-2022)
Table 21. Global Prostate Cancer Molecular Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 22. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Type (2023-2028)
Table 23. Global Prostate Cancer Molecular Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 24. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Application (2017-2022)
Table 25. Global Prostate Cancer Molecular Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 26. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Application (2023-2028)
Table 27. North America Prostate Cancer Molecular Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 28. North America Prostate Cancer Molecular Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 29. North America Prostate Cancer Molecular Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 30. North America Prostate Cancer Molecular Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 31. North America Prostate Cancer Molecular Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 32. North America Prostate Cancer Molecular Diagnostics Revenue by Country (2017-2022) & (US$ Million)
Table 33. North America Prostate Cancer Molecular Diagnostics Revenue by Country (2023-2028) & (US$ Million)
Table 34. Europe Prostate Cancer Molecular Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 35. Europe Prostate Cancer Molecular Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 36. Europe Prostate Cancer Molecular Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 37. Europe Prostate Cancer Molecular Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 38. Europe Prostate Cancer Molecular Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 39. Europe Prostate Cancer Molecular Diagnostics Revenue by Country (2017-2022) & (US$ Million)
Table 40. Europe Prostate Cancer Molecular Diagnostics Revenue by Country (2023-2028) & (US$ Million)
Table 41. Asia Pacific Prostate Cancer Molecular Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 42. Asia Pacific Prostate Cancer Molecular Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 43. Asia Pacific Prostate Cancer Molecular Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 44. Asia Pacific Prostate Cancer Molecular Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 45. Asia Pacific Prostate Cancer Molecular Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 46. Asia Pacific Prostate Cancer Molecular Diagnostics Revenue by Region (2017-2022) & (US$ Million)
Table 47. Asia Pacific Prostate Cancer Molecular Diagnostics Revenue by Region (2023-2028) & (US$ Million)
Table 48. Latin America Prostate Cancer Molecular Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 49. Latin America Prostate Cancer Molecular Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 50. Latin America Prostate Cancer Molecular Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 51. Latin America Prostate Cancer Molecular Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 52. Latin America Prostate Cancer Molecular Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 53. Latin America Prostate Cancer Molecular Diagnostics Revenue by Country (2017-2022) & (US$ Million)
Table 54. Latin America Prostate Cancer Molecular Diagnostics Revenue by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Prostate Cancer Molecular Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 56. Middle East and Africa Prostate Cancer Molecular Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Prostate Cancer Molecular Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Prostate Cancer Molecular Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Prostate Cancer Molecular Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Prostate Cancer Molecular Diagnostics Revenue by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Prostate Cancer Molecular Diagnostics Revenue by Country (2023-2028) & (US$ Million)
Table 62. Qiagen Company Details
Table 63. Qiagen Business Overview
Table 64. Qiagen Prostate Cancer Molecular Diagnostics Product and Services
Table 65. Qiagen Prostate Cancer Molecular Diagnostics Revenue in Prostate Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 66. Qiagen Prostate Cancer Molecular Diagnostics SWOT Analysis
Table 67. Qiagen Recent Developments
Table 68. Foundationmedicine Company Details
Table 69. Foundationmedicine Business Overview
Table 70. Foundationmedicine Prostate Cancer Molecular Diagnostics Product and Services
Table 71. Foundationmedicine Prostate Cancer Molecular Diagnostics Revenue in Prostate Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 72. Foundationmedicine Prostate Cancer Molecular Diagnostics SWOT Analysis
Table 73. Foundationmedicine Recent Developments
Table 74. Genetech Company Details
Table 75. Genetech Business Overview
Table 76. Genetech Prostate Cancer Molecular Diagnostics Product and Services
Table 77. Genetech Prostate Cancer Molecular Diagnostics Revenue in Prostate Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 78. Genetech Prostate Cancer Molecular Diagnostics SWOT Analysis
Table 79. Genetech Recent Developments
Table 80. Gpmedical Company Details
Table 81. Gpmedical Business Overview
Table 82. Gpmedical Prostate Cancer Molecular Diagnostics Product and Services
Table 83. Gpmedical Prostate Cancer Molecular Diagnostics Revenue in Prostate Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 84. Gpmedical Prostate Cancer Molecular Diagnostics SWOT Analysis
Table 85. Gpmedical Recent Developments
Table 86. Premed Company Details
Table 87. Premed Business Overview
Table 88. Premed Prostate Cancer Molecular Diagnostics Product and Services
Table 89. Premed Prostate Cancer Molecular Diagnostics Revenue in Prostate Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 90. Premed Prostate Cancer Molecular Diagnostics SWOT Analysis
Table 91. Premed Recent Developments
Table 92. Berryoncology Company Details
Table 93. Berryoncology Business Overview
Table 94. Berryoncology Prostate Cancer Molecular Diagnostics Product and Services
Table 95. Berryoncology Prostate Cancer Molecular Diagnostics Revenue in Prostate Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 96. Berryoncology Prostate Cancer Molecular Diagnostics SWOT Analysis
Table 97. Berryoncology Recent Developments
Table 98. Gene+ Company Details
Table 99. Gene+ Business Overview
Table 100. Gene+ Prostate Cancer Molecular Diagnostics Product and Services
Table 101. Gene+ Prostate Cancer Molecular Diagnostics Revenue in Prostate Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 102. Gene+ Prostate Cancer Molecular Diagnostics SWOT Analysis
Table 103. Gene+ Recent Developments
Table 104. Annoroad Company Details
Table 105. Annoroad Business Overview
Table 106. Annoroad Prostate Cancer Molecular Diagnostics Product and Services
Table 107. Annoroad Prostate Cancer Molecular Diagnostics Revenue in Prostate Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 108. Annoroad Prostate Cancer Molecular Diagnostics SWOT Analysis
Table 109. Annoroad Recent Developments
Table 110. Topgen Company Details
Table 111. Topgen Business Overview
Table 112. Topgen Prostate Cancer Molecular Diagnostics Product and Services
Table 113. Topgen Prostate Cancer Molecular Diagnostics Revenue in Prostate Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 114. Topgen Prostate Cancer Molecular Diagnostics SWOT Analysis
Table 115. Topgen Recent Developments
Table 116. Geneis Company Details
Table 117. Geneis Business Overview
Table 118. Geneis Prostate Cancer Molecular Diagnostics Product and Services
Table 119. Geneis Prostate Cancer Molecular Diagnostics Revenue in Prostate Cancer Molecular Diagnostics Business (2017-2022) & (US$ Million)
Table 120. Geneis Prostate Cancer Molecular Diagnostics SWOT Analysis
Table 121. Geneis Recent Developments
Table 122. Prostate Cancer Molecular Diagnostics Market Trends
Table 123. Prostate Cancer Molecular Diagnostics Market Drivers
Table 124. Prostate Cancer Molecular Diagnostics Market Challenges
Table 125. Prostate Cancer Molecular Diagnostics Market Restraints
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Molecular Diagnostics Sales Market Share by Type: 2021 VS 2028
Figure 2. PCR Features
Figure 3. FISH Features
Figure 4. DNA Sequencing Features
Figure 5. Gene Chip Features
Figure 6. Global Prostate Cancer Molecular Diagnostics Sales Market Share by Application: 2021 VS 2028
Figure 7. Clinical Diagnosis Case Studies
Figure 8. Drug Screening Case Studies
Figure 9. Research Case Studies
Figure 10. Prostate Cancer Molecular Diagnostics Report Years Considered
Figure 11. Global Prostate Cancer Molecular Diagnostics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Prostate Cancer Molecular Diagnostics Market Size 2017-2028 (US$ Million)
Figure 13. Global Prostate Cancer Molecular Diagnostics Market Size Market Share by Region: 2021 VS 2028
Figure 14. Global Prostate Cancer Molecular Diagnostics Revenue Market Share by Region in 2017 VS 2022
Figure 15. Global Top 10 Prostate Cancer Molecular Diagnostics Countries Ranking by Market Size (US$ Million) in 2021
Figure 16. Global Prostate Cancer Molecular Diagnostics Market Share by Players in 2021
Figure 17. Global Top Prostate Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Molecular Diagnostics as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Prostate Cancer Molecular Diagnostics Revenue in 2021
Figure 19. North America Prostate Cancer Molecular Diagnostics Revenue Market Share by Company in 2021
Figure 20. North America Prostate Cancer Molecular Diagnostics Revenue Market Share by Type (2017-2028)
Figure 21. North America Prostate Cancer Molecular Diagnostics Revenue Market Share by Application (2017-2028)
Figure 22. North America Prostate Cancer Molecular Diagnostics Revenue Share by Country (2017-2028)
Figure 23. United States Prostate Cancer Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 24. Canada Prostate Cancer Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 25. Europe Prostate Cancer Molecular Diagnostics Revenue Market Share by Company in 2021
Figure 26. Europe Prostate Cancer Molecular Diagnostics Revenue Market Share by Type (2017-2028)
Figure 27. Europe Prostate Cancer Molecular Diagnostics Revenue Market Share by Application (2017-2028)
Figure 28. Europe Prostate Cancer Molecular Diagnostics Revenue Share by Country (2017-2028)
Figure 29. Germany Prostate Cancer Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 30. France Prostate Cancer Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 31. U.K. Prostate Cancer Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 32. Italy Prostate Cancer Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 33. Russia Prostate Cancer Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Prostate Cancer Molecular Diagnostics Revenue Market Share by Company in 2021
Figure 35. Asia Pacific Prostate Cancer Molecular Diagnostics Revenue Market Share by Type (2017-2028)
Figure 36. Asia Pacific Prostate Cancer Molecular Diagnostics Revenue Market Share by Application (2017-2028)
Figure 37. Asia Pacific Prostate Cancer Molecular Diagnostics Revenue Share by Region (2017-2028)
Figure 38. China Prostate Cancer Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 39. Japan Prostate Cancer Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 40. South Korea Prostate Cancer Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 41. India Prostate Cancer Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 42. Australia Prostate Cancer Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 43. China Taiwan Prostate Cancer Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 44. Indonesia Prostate Cancer Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 45. Thailand Prostate Cancer Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 46. Malaysia Prostate Cancer Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 47. Latin America Prostate Cancer Molecular Diagnostics Revenue Market Share by Company in 2021
Figure 48. Latin America Prostate Cancer Molecular Diagnostics Revenue Market Share by Type (2017-2028)
Figure 49. Latin America Prostate Cancer Molecular Diagnostics Revenue Market Share by Application (2017-2028)
Figure 50. Latin America Prostate Cancer Molecular Diagnostics Revenue Share by Country (2017-2028)
Figure 51. Mexico Prostate Cancer Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 52. Brazil Prostate Cancer Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 53. Argentina Prostate Cancer Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 54. Middle East and Africa Prostate Cancer Molecular Diagnostics Revenue Market Share by Company in 2021
Figure 55. Middle East and Africa Prostate Cancer Molecular Diagnostics Revenue Market Share by Type (2017-2028)
Figure 56. Middle East and Africa Prostate Cancer Molecular Diagnostics Revenue Market Share by Application (2017-2028)
Figure 57. Middle East and Africa Prostate Cancer Molecular Diagnostics Revenue Share by Country (2017-2028)
Figure 58. Turkey Prostate Cancer Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 59. Saudi Arabia Prostate Cancer Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 60. UAE Prostate Cancer Molecular Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 61. Qiagen Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2017-2022)
Figure 62. Foundationmedicine Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2017-2022)
Figure 63. Genetech Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2017-2022)
Figure 64. Gpmedical Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2017-2022)
Figure 65. Premed Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2017-2022)
Figure 66. Berryoncology Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2017-2022)
Figure 67. Gene+ Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2017-2022)
Figure 68. Annoroad Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2017-2022)
Figure 69. Topgen Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2017-2022)
Figure 70. Geneis Revenue Growth Rate in Prostate Cancer Molecular Diagnostics Business (2017-2022)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
In-depth database
Our Report’s database covers almost all topics of all regions over the Globe..
Recognised publishing sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales support.
Safe & Secure
Complete secure payment process.
: sales@marketintelligencedata.com
: 1137 waynewood dr,Waxhaw NC 28173 ,United States
: +1 (704) 266-3234
